Literature DB >> 17586614

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

Shawna A Cooper1, Adam Whaley-Connell, Javad Habibi, Yongzhong Wei, Guido Lastra, Camila Manrique, Sameer Stas, James R Sowers.   

Abstract

Hypertension commonly occurs in conjunction with insulin resistance and other components of the cardiometabolic syndrome. Insulin resistance plays a significant role in the relationship between hypertension, Type 2 diabetes mellitus, chronic kidney disease, and cardiovascular disease. There is accumulating evidence that insulin resistance occurs in cardiovascular and renal tissue as well as in classical metabolic tissues (i.e., skeletal muscle, liver, and adipose tissue). Activation of the renin-angiotensin-aldosterone system and subsequent elevations in angiotensin II and aldosterone, as seen in cardiometabolic syndrome, contribute to altered insulin/IGF-1 signaling pathways and reactive oxygen species formation to induce endothelial dysfunction and cardiovascular disease. This review examines currently understood mechanisms underlying the development of resistance to the metabolic actions of insulin in cardiovascular as well as skeletal muscle tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586614     DOI: 10.1152/ajpheart.00522.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  103 in total

1.  Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.

Authors:  Eduardo Pimenta; Richard D Gordon; Ashraf H Ahmed; Diane Cowley; Rodel Leano; Thomas H Marwick; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

Review 2.  Blood pressure lowering in patients with diabetes--one level might not fit all.

Authors:  Rhonda M Cooper-DeHoff; Eric F Egelund; Carl J Pepine
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

Review 3.  Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.

Authors:  Jun Ren; Lakshmi Pulakat; Adam Whaley-Connell; James R Sowers
Journal:  J Mol Med (Berl)       Date:  2010-08-20       Impact factor: 4.599

Review 4.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

5.  Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults.

Authors:  Jennifer N Cooper; Ping Tepper; Emma Barinas-Mitchell; Genevieve A Woodard; Kim Sutton-Tyrrell
Journal:  Clin Exp Hypertens       Date:  2011-10-18       Impact factor: 1.749

Review 6.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

7.  Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs.

Authors:  Michael W Brands; Tracy D Bell; Nancy A Rodriquez; Praveen Polavarapu; Dmitriy Panteleyev
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

Review 8.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

9.  Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Authors:  Adam Whaley-Connell; Ravi Nistala; Javad Habibi; Melvin R Hayden; Rebecca I Schneider; Megan S Johnson; Roger Tilmon; Nathan Rehmer; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

10.  Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.

Authors:  Adam Whaley-Connell; Javad Habibi; Megan Johnson; Roger Tilmon; Nathan Rehmer; Jenna Rehmer; Charles Wiedmeyer; Carlos M Ferrario; James R Sowers
Journal:  Am J Nephrol       Date:  2009-07-17       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.